Sandoz Canada News


New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine

Sandoz Canada President Michel Robidoux honoured at LES NOUVEAUX PERFORMANTS 2017 Gala

Sandoz Canada launches Sandoz® Amphetamine XR for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)

FDA approves Sandoz Erelzi™ to treat multiple inflammatory diseases

New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product

Sandoz Canada Regulatory Submission for Subsequent Entry Biologic Etanercept Accepted for Review by Health Canada

Sandoz Canada Launches First Non-Prescription Naloxone Approved by Health Canada for Treating Opioid Overdoses

Sandoz announces plans for five major global biosimilar launches by 2020

Sandoz Canada concludes a new collective agreement with unionized employees at its Boucherville plant

New data demonstrates sandoz’ etanercept and rituximab biosimilar candidates bioequivalent to originator products.

Sandoz Canada is committed to maintain a supply of injectable medicines during work stoppage by unionized employees at its Boucherville facility.

Sandoz broadens its pharmaceutical portfolio with EURO-PHARM's North American product line.

Welcome to Sandoz Canada

Health is our most precious asset. That’s why, at Sandoz Canada, we respond to our customers’ needs by acting quickly to offer an unparalleled range of high-quality, affordable generic products. But that’s not all. Our vision goes beyond the production of standard generic products. We lead by example. We develop and market a wide range of differentiated products that make a real difference. We help cure patients and save lives. Because our priority is people, whether they are our patients, our pharmacists, our business partners or our employees.

Sandoz Careers


Our people are our greatest resource. We are always looking for new colleagues to share in our passion and commitment to making the world a healthier place.

Customer Service Survey

Your opinion matters ! Rate our Customer Service.

Click here to complete our survey.


New Products

Sandoz broadens its pharmaceutical portfolio with EURO-PHARM's North American product line.

To learn more on these products,

click here.


S.O.S. NaloxoneTM Hydrochloride Injection

New OTC Naloxone Hydrochloride Injection available for sale in Canada without a prescription.

Click here to see a demonstration video explaining the administration of naloxone.

Click here for the Consumer Information Leaflet.


Sandoz® Fentanyl
Patch Return Sheet

Click here for more information



Sandoz  History


Take a virtual journey into the historical roots of our company.

Explore our history >



 Don’t throw them out, visit

Slideshow Background Images